Switch to:
More From Other Websites
Amgen Announces New Data from Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study in Patients... Dec 07 2014
Amgen and Onyx Announce Detailed Results from Phase 3 ASPIRE Study of Kyprolis® (carfilzomib) in... Dec 06 2014
Amgen Highlights New Data in The Treatment of Blood Cancers at ASH 2014 Nov 06 2014
Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for... Mar 11 2014
Amgen 4Q profit leaps 30 percent on higher sales Jan 28 2014
Amgen 4Q profit leaps 30 percent on higher sales Jan 28 2014
Amgen Q4 profit leaps 30 percent on higher sales Jan 28 2014
Amgen Q4 profit leaps 30 percent on higher sales Jan 28 2014
Best Call of 2013: Onyx Pharmaceuticals Dec 31 2013
AstraZeneca buys US cancer drugs firm Aug 27 2013
US biotech giant Amgen to buy rival Onyx for $10.4 bln Aug 25 2013


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK